Termino C 10072 AB

ABDissolved

Org 5568086697Research and experimental development on biotechnology · NACE 7211Est. 20100 employees

Overview Financials People & ownership Related companies

Termino C 10072 AB is a Swedish AB, operating in the Bioteknisk forskning och utveckling sector. Incorporated in 2010, the company has 0 employees and reported revenue of SEK 0 in its latest annual filing.

Revenue 2023

SEK 0

EBITDA margin

—

-250% vs 2022

Equity ratio

74.4%

Financial strength

Net profit 2023

SEK -28K

-256% vs 2022

EBITDA — year on year

SEK millions

Key figures

Annual report 2023

Revenue	SEK 0	—
EBITDA	SEK -28K	-250%
Net profit	SEK -28K	-256%
Total assets	SEK 39K	-46%
Equity	SEK 29K	-49%
Employees	0	—

Contact

Address

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Termino C 10072 AB?

Termino C 10072 AB is registered with Bolagsverket / SCB under Org 5568086697.

Who is the chairman of Termino C 10072 AB?

Anders Jakob Lindquist chairs the board of Termino C 10072 AB, in role since 2022.

Termino C 10072 AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Termino C 10072 AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Termino C 10072 AB